The program schedule is subject to change.

  • Tuesday 29 May 2018
  • 18:00
    Welcome Reception

    at the Muziekgebouw aan ’t IJ
  • Wednesday 30 May 2018
  • 08:00
    Opening remarks

  • Scientific Session 1: Updates in Vascular Anomalies, Bench and Bedside

    Moderators: Ilona Frieden & Steven Fishman
    • 08:15
      O001 Patient-reported outcomes of bleomycin sclerotherapy for low flow vascular malformations and predictors of improvement.

      Sophie E.R. Horbach, Joost S. van de Ven, Pythia T. Nieuwkerk, Phyllis I. Spuls, Chantal M.A.M. van der Horst and Jim A. Reekers
    • 08:24
      O002 Efficacy and Safety of Pre-Operative Glue Embolization in Treatment of Head and Neck Venous Malformations

      Jonathan Perkins
    • 08:33
      O003 Embryonic Stem Cell-like Subpopulations in Venous Malformation

      Elysia Tan, Sam Siljee, Helen Brasch, Jennifer de Jongh, Susana Enriquez, Swee Tan and Tinte Itinteang
    • 08:42
      O004 CD133+ cells isolated from venous malformation recapitulate the clinical phenotype in a mouse mode

      Peter Grzesik, Michael Schonning, Seung Koh, Ravi Sun, Andrew K. Edwards, Alison Kitajewski, Gresham T. Richter, Carrie J. Shawber and June Wu
    • 08:51
      O005 Retrospective Study of Hematologic Complications in Patients with Localized Intravascular Coagulopathy Undergoing Sclerotherapy

      Kiersten Ricci, Adrienne Hammill, Carol Chute, Paula Mobberley-Schuman, Roshni Dasgupta and Manish Patel
    • 09:00
      O006 Venous malformations and blood coagulation in children

      Johanna Aronniemi, Katariina A. Mattila, Anne Mäkipernaa, Päivi Salminen, anne Pitkäranta, Johanna Pekkola and Riitta Lassila
    • 09:08
      O007 Effect of Sirolimus on Coagulopathy of Slow-flow Vascular Malformations

      Bethany Verkamp, Joana Mack, Gresham Richter, Kelly Stewart and Shelley Crary
    • 09:18
      O008 Efficacy and Safety of Sirolimus in Vascular Malformations Refractory to Standard Care: Preliminary Results of a Phase III Clinical Trial VASE

      Emmanuel Seront, Jennifer Hammer, An Van Damme, Anne Dompmartin, Marie Antoinette Sevestre, Jochen Rössler, Annouk Bisdorff Bresson, Isabelle Quere, Sandra Schmitz, Philippe Clapuyt, Frank Hammer, Catherine Legrand, Miikka Vikkula and Laurence Boon
    • 09:27
      O009 ABL kinase inhibitor Ponatinib combined with rapamycin causes regression of murine Venous Malformation

      Xian Li, Yuqi Cai, Jillian Goines, Patricia Pastura, Paula Mobberley-Schuman, Megan Metcalf, Adrienne Hammill, Denise Adams, Tim LeCras and Elisa Boscolo
    • 09:36
      O010 Initial Experience of Intravascular Sclerotherapy with C-arm Scan under the Guidance of Computer Navigation for Low-flow Vascular Malformations in the Complicated Anatomic Regions of Head and Neck: Report on 8 Procedures

      Hao Gu, Hui Chen, Zimin Zhang, Yunbo Jin, Xi Yang, Li Hu, Yongying Wang and Lin Xiaoxi
    • 09:45
      O011 Sclerotherapy For Intramuscular Vascular Malformations: A Single Center Experience

      Federico Scorletti, Manish Patel, Adrienne Hammill, Kiersten Ricci, Charles Myers and Roshni Dasgupta
    • 09:54
      O012 Venous Malformations are Proliferative: Clinical Implications

      Michael Schonning, Ajit Muley, Seung Koh, Peter Grzesik, Carrie J. Shawber and June Wu
    • 10:03
      O013 The European Reference Network (ERN) for rare vascular diseases (VASCERN): VASCA-working group - towards better management of vascular anomaly patients

      Miikka Vikkula, Leo Schultze Kool, Alan Irvine, Päivi Salminen, Nader Ghaffarpour, Andrea Diociaiuti, Jochen Rössler, C.T. van den Bosch, Eulalia Baselga, Anne Dompmartin and Laurence Boon
    • 10:12
      O014 Outcome measurement instruments for peripheral vascular malformations (OVAMA project)

      Amber P. Rongen, Sophie E.R. Horbach, Roy G. Elbers, Chantal M.A.M. van der Horst, Cecilia A.C. Prinsen, Phyllis I. Spuls and OVAMA consensus group
  • 10:20
    Coffee Break
  • Summary Advanced Specialty Sessions
    • 10:45
      Interventional Radiology
    • 10:56
    • 11:07
    • 11:18
  • 11:30
    Keynote: Lessons learned from our patients: Questions, Investigation, Solutions

    Steven FIshman, Boston Children’s Hospital, Boston, USA
  • 12:15
    Lunch & Poster presentations P001-P058; P145-P156; & P191-219
  • Difficult Cases 1

    Moderators: Alejandro Berenstein & Julie Prendiville
    • 13:45
      O015 Fœtal pulmonary and cerebral arterio-venous malformations as presenting signs of RASA-1 CM-AVM syndrome

      Julie Powell, Aspasia Karalis, Sandrine Essouri, Denis Bérubé and Josee Dubois
    • 13:56
      O016 Cerebral Proliferative Angiopathy associated with Multiple Capillary Malformations : A new Rasopathy ?

      Anne Dompmartin
  • Scientific Session 2: Vascular Malformations 1

    Moderators: Douglas Marchuk & Annouk Bisdorff-Bresson
    • 14:11
      O017 Wall shear stress in the feeding artery of a superficial arteriovenous malformation is an early and reliable marker of progression.

      Imane El Sanharawi, Didier Salvan, Gabrielle Mangin Mangin, Adrien Cogo, Stephanie Lenck, Olivier Baillart, Nathalie Kubis, Annouk Bisdorff Bresson and Philippe Bonnin
    • 14:20
      O018 The use of Bleomycin and a Thrombin –Gelatin Hemostatic Matrix in the Treatment of Recurrent or Residual High Flow Arteriovenous Malformations of the Head and Neck

      Alejandro Berenstein
    • 14:29
      O019 Efficacy of an AVM Classification System that Directs Endovascular Therapies Accurately

      Wayne Yakes
    • 14:38
      O020 Extracranial artreriovenous malformations: a classification based on clinical, surgical and endovascular features.

      Giacomo Colletti, Margherita Dessy, Laura Moneghini, Anna Ierardi, Raul Mattassi and Federico Biglioli
    • 14:47
      O021 Germline Loss-of-Function Mutations in EPHB4 cause a Second Form of Capillary Malformation–Arteriovenous Malformation (CM-AVM2) deregulating RAS-MAPK signaling

      Nicole Revencu, Mustapha Amyere, Raphaël Helaers, Eleonore Pairet, Eulalia Baselga, Maria Cordisco, Wendy Chung, Josee Dubois, Jean-Philippe Lacour, Loreto Martorell, Juliette Mazereeuw-Hautier, Reed E. Pyeritz
    • 14:56
      O022 Expanding the phenotypic spectrum of cases with an EPHB4 mutation

      Whitney Wooderchak-Donahue, Gulsen Akay Tayfun, Jamie McDonald, Kevin Whitehead, David Stevenson and Pinar Bayrak-Toydemir
    • 15:03
      O023 EPH-B4 Regulates Venous Adaptive Remodeling in Arteriovenous Fistulas via an AKT1-Dependent Mechanism

      Naiem Nassiri and Alan Dardik
    • 15:10
      O024 Genetic Testing in the Diagnostic Workup of Vascular Anomalies

      Miikka Vikkula, Nicole Revencu, Anne Dompmartin, Elsa Khoury, Antonella Mendola, Nisha Limaye, Raphaël Helaers, Elodie Fastré, Matthieu Schlögel, Nassim Homayun, Pascal Brouillard and Laurence Boon
    • 15:19
      O025 Clinical Utility of a NGS panel in the Diagnosis of Vascular Malformations Syndromes

      Whitney Wooderchak-Donahue, Gulsen Akay-Tayfun, Peter Johnson, Jamie McDonald, J. Fredrik Grimmer, Gresham Richter, Marcie Steeves, Angela Lin, David Stevenson and Pinar Bayrak-Toydemir
    • 15:26
      O026 Molecular Diagnosis of Mosaic Skin Development Disorders using Next Generation Sequencing.

      Virginie Carmignac, Paul Kuentz, Arthur Sorlin, Martin Chevarin, Thibaud Jouan, Charlotte Poë, Yannis Duffourd, Frédéric Tran Mau Them, Christel Thauvin, Christophe Philippe, Jean-Baptiste Rivière, Laurence Faivre, Pierre Vabres and Investigators MUSTARD
    • 15:33
      O027 ISSVA Classification of Vascular Anomalies. 2018 Update Proposal.

      Michel Wassef, Eulalia Baselga, Gulraiz Chaudry, Maria Garzon, Dov Goldenberg, Juan-Carlos Lopez-Gutierrez, David Lord, Tony Penington, Julie Prendiville, June Wu and Francine Blei
  • 15:45
    Coffee Break
  • 16:00
    General Assembly
  • 17:30
    Social Event: Boat Tour

  • Thursday 31 May 2018
  • Scientific Session 3: Vascular Malformations 2

    Moderator: Miikka Vikkula
    • 08:00
      O028 Endothelial Cell Lineage Tracing in Cerebral Cavernous Malformations: A Modification of the “Two-Hit” Mutation Model of CCM Pathogenesis.

      Matthew Detter and Douglas Marchuk
    • 08:09
      O029 Rapamycin not shown to inhibit LM growth in a mouse xenograft model.

      Tony Penington, Zerina Lokmic and Nerida Sleebs
    • 08:18
      O030 Activation Of AKT In Tissue Endothelial Cells & Elevated Serum ANG-2 levels in Patients With Capillary Lymphatic Venous Malformations

      Tim LeCras, Jillian Goines, patricia pastura, Paula Mobberley-Schuman, Megan Metcalf, Denise Adams, Adrienne Hammill and Elisa Boscolo
    • 08:27
      O031 Laser Ablation of Lymphatic Malformation Using Nanoparticle Targeted Therapy

      Ravi Sun, Ekaterina Galanzha, Dmitry Nedosekin, Haihong Zhang, Ting Wei, Zerina Lokmic, June Wu, Tony Penington, Vladimir Zharov and Gresham Richter
    • 08:36
      O032 Excessive PI3K/mTOR signaling causes lymphatic hyperplasia and dysfunction in mice

      Devon Hominick, Noor Khurana, Lara Rodriguez-Laguna, Noelia Agra, Gema Gordo, Pablo Lapunzina, Juan C. Lopez-Gutierrez, Victor Martinez-Glez and Michael Dellinger
    • 08:43
      O033 Gene Expression Detected in Peripheral Blood of Patients with Lymphatic Malformation

      Joyce Teng, Kavita Sarin, Taehan Kim, Ramie Lekwuttikan, Elidia Tafoya and Malcolm Chelliah
    • 08:50
      O034 Superficial Cutaneous Vascular Malformations and Other Skin Manifestations of the PIK3CA-Related Overgrowth Spectrum (PROS)

      Justine Pasteur, Paul Kuentz, Yannis Duffourd, Arthur Sorlin, Laurence Faivre, Christelle Thauvin, Jean-Baptiste Rivière, Pierre Vabres and Investigators of MUSTARD Cohort
    • 08:57
      O035 The full spectrum of post-zygotic PIK3CA mutations in non-syndromic lymphatic malformations

      James Bennett, Chi Cheng, Dana Jensen, Andrew Timms, Sheila Ganti, Giri Shivaram, Randall Bly, Andrew Kirsh, William Dobyns, Mark Makesky and Jonathan Perkins
    • 09:04
      O036 Activating mutations in PIK3CA are specifically localized in lymphatic malformation-derived lymphatic endothelial cells of young children: therapeutic implications

      Jochen Rössler, Hannah Blesinger, Juergen Becker, Silke Kaulfuss and Jörg Wilting
    • 09:11
      O037 Safety and Efficacy of Low Dose Sirolimus in Patients with PIK3CA-Related Overgrowth

      Victoria Parker, Kim M. Keppler-Noreuil, Pierre Vabres, Leena De Silva, Julie C. Sapp, Maxime Luu, Marjorie J. Lindhurst, Elodie Gautier, Marc Bardou, Laurence Faivre, Robert Semple and Leslie G. Biesecker
    • 09:18
      O038 Segmental Overgrowth in Syndromic Vascular Anomalies: Towards a Pharmacogenetic Therapy with Rapamycin

      V. Baraldini, L. Spaccini , E. Cattaneo , D. Graziani, L. Moneghini, G. Bulfamante
    • 09:25
      O039 “PTEN hamartoma of soft tissue” may also be related to PIK3CA mutations.

      Olivia Boccara, Louise Galmiche-Rolland, Bérengère Dadone, Stéphanie Pannier, Véronique Soupre, Florence Pedeutour and Sylvie Fraitag
    • 09:32
      O040 How to build a multi-disciplinary vascular anomalies clinic from scratch: Lessons learned from a large, tertiary-care American children’s hospital

      C. Matthew Hawkins, Steven Goudy, Michael Briones, Rachel Swerdlin, Jonathan Meisel, Sarah Milla, Magdalena Soldanska and Leslie Lawley
    • 09:39
      O041 A FAIR compliant registry for the vascular malformation centres within the European Reference Networks. How it was done

      Leo Schultze Kool, Alan IRVINE, Päivi Salminen, Nader Ghaffarpour, Andrea Diociaiuti, Jochen Rössler, C.T. van den Bosch, Eulalia Baselga, Anne Dompmartin, Laurence Boon, Miikka Vikkula, Luiz Bonino, Mark Thompson, Annika Jacobsen, David van Enckevort and Marco Roos
    • 09:46
      O042 The European Reference Network (ERN) criteria for multidisciplinary vascular anomaly clinics (VASCA) in the VASCERN

      Jochen Rössler, Eulalia Baselga, Laurence Boon, Andrea Diociaiuti, Anne Dompmartin, Nader Ghaffarpour, Alan D Irvine, Paivi Salminen, Leo SchultzeKool, Caroline van den Bosch and Miikka Vikkula
    • 09:54
      O043 Patient involvement on vascular anomalies in the European Reference Network VASCERN

      C.T. van den Bosch, Matt Bolz-Johnson, Miikka Vikkula, Leo Schultze Kool, Jochen Rössler, Eulalia Baselga, Laurence Boon, Andrea Diociaiuti, Anne Dompmartin, Nader Ghaffarpour, Alan Irvine, Päivi Salminen, Maria Barea, Ange van der Velden and Petra Borgar
  • 10:00
    Coffee Break
  • Difficult Cases 2

    Moderators: Juan Carlos Lopez-Guttierez & Denise Adams
    • 10:30
      O044 Syndromic segmental arterio-venous malformation: a therapeutic challenge

      Olivia Boccara, Annouk Bisdorff Bresson, Diala Khraiche, Olivier Naggara, Timothée de Saint-Denis, Paul Kuentz, Smail Hadj-Rabia, Francis Brunelle and Stéphanie Pannier
    • 10:39
      O045 A difficult case of upper limb venous malformation with intolerance to oral sirolimus

      Mei-Yoke Chan, Luke Toh and Mark Koh
    • 10:48
      O046 Management challenges of a complex CLOVES Syndrome patient with severe scoliosis and lipomatous overgrowth

      Wesley Barry, Donna Nowicki, Minnelly Luu, Chadi Zeinati, Lori Howell and Dean Anselmo
    • 10:57
      O047 Case Report: Management of Menorrhagia in a Young Woman with Blue Rubber Bleb Nevus Syndrome: Failures and Successes

      Carrie Terrell, Sheilagh Maguiness and Brenda Weigel
  • Scientific Session 4: Vascular Malformations 3

    Moderators: Gerald M. Legiehn & David Lord
    • 11:10
      O048 Prevalence of Cardiac Failure in Patients with Arteriovenous Malformations

      Megan Gaffey, Megan Scarbrough, Ravi Sun, Joseph Deloach, James Suen and Gresham Richter
    • 11:19
      O049 PET/CT imaging of angiogenesis in arteriovenous malformations

      Daphne Lobeek, Mark Rijpkema, Miikka Vikkula, Laurence Boon, Frédérique Bouwman, Willemijn Klein, Erik Aarntzen and Leo Schultze Kool
    • 11:26
      O050 Melorheostosis and vascular anomalies caused by somatic mosaicism of KRAS

      Minia Campos-Domínguez, Víctor Martínez-Glez, Verónica Seidel, Teresa Martínez-Menchón, Belén Ferri Ñiguez, Antonio Cervantes Pardo, Ángel Lancharro-Zapata, Yolanda Ruiz-Martín, Antonio Salcedo-Posadas, Jorge Huerta-Aragonés, Carmen Garrido-Colino, Beatriz Berenguer-Fröhner, Elena De Tomás-Palacios, Concepción Lorca-García and Rosario García-Pajares
    • 11:33
      O051 Extracranial Arteriovenous Malformations (AVMs) Are Caused by Activating MAP2K1 Mutations In Endothelial Cells

      Javier A. Couto, August Yue Huang, Patrick J. Smits, Dennis J. Konczyk, Jeremy A. Goss, Steven J. Fishman, John B. Mulliken, Matthew L. Warman, Arin K. Greene
    • 11:43
      O052 Mosaic RAS/MAPK variants cause sporadic vascular malformations which respond to targeted therapy

      Satyamaanasa Polubothu, Mary Glover, Lara Al-Olabi, Katherine Dowsett, Katrina Andrews, Paulina stadnik, Agnel P Joseph, Rachel Knox, Alan Pittman, Graeme Clark, William Baird, Neil Bulstrode, Kristiana Gordon, Darren Hargrave, Sue Huson, Thomas Jacques, Gregory James, Hannah Kondolf, Loshan Kangesu, Kim Keppler-noreuil, Amjad Khan, Marjorie Lindhurst, Mark Lipson
    • 11:52
      O053 The Role of Notch Pathway Components in Extracranial Arteriovenous Malformations

      Ting Wei, Haihong Zhang, Ravi Sun and Gresham Richter
  • 12:00
    Lunch & Poster Presentations P059-P144 & P157-P190

  • Scientific Session 5: Hemangiomas and Vascular Tumors

    Moderators: Eulalia Baselga & Maria Garzon
    • 13:30
      O054 Source of Elevated AFP Levels in Infantile Haemangioma

      Tinte Itinteang, Matthew Munro, Bede van Schaijik, Jennifer de Jongh, Erin Paterson, Reginald Marsh and Swee Tan
    • 13:37
      O055 Resistance Index (RI) in Colour Coded Duplex Sonography (CCDS) Easy Use and Reliable Results in the Determination of Activity in Infantile Hemangiomas

      Peter Urban
    • 13:44
      O056 Non-involuting congenital hemangiomas (NICH) with post-natal atypical growth: a case series

      Maria Cossio, Josee Dubois, Catherine McCuaig, Danielle Marcoux, Sandra Ondrejchak and Julie Powell
    • 13:51
      O057 Tardive Expansion Congenital Hemangioma: a variation of NICH or a new hemangiomatous entity?

      Chen Hua, Yunbo Jin, Lizhen Wang, Hui Chen, Gang Ma, Yajing Qiu and Lin Xiaoxi
    • 13:58
      O058 Use of the Hemangioma Severity Scale to facilitate treatment decisions for infantile hemangiomas

      Carine Van der Vleuten and Andre Moyakine
    • 14:07
      O059 Multiple cutaneous and visceral GLUT-1 positive congenital vascular tumors: a novel entity or a variant of multifocal infantile hemangiomatosis.

      Esperanza Mantilla-Rivas, Pamela Tan, Jocelyn C Zajac, Alexandra Tilt, Nancy Bauman, Philip Guzzetta, Gina Krakovsky, Bhupender Yadav, Ana Yasmine Kirkorian and Albert Oh
    • 14:14
      O060 Systemic Timolol Exposures Following Topical Application to Infantile Hemangiomas

      Beth Drolet, Felix Boakye-Agyeman, Sarah Chamlin, Scott Denne, Anita Haggstrom, Barrie Harper, Kristen Holland, Jan Hau Lee, Hui Min Liew, Andrew Lewandowski, Casey Gelber, Anthony Mancini, Dawn Siegel, Nicole Stefanko, Rami Yogev and Chiara Melloni
    • 14:23
      O061 Efficacy and Safety of Topical Timolol Maleate 0.5% Solution for Infantile Hemangioma in Early Proliferative Phase. A Randomized Clinical Trial

      Fania Muñoz Garza, Mónica Ríos Varela, Esther Roé Crespo, Lluis Puig Sanz, José Bernabeu Wittel and Eulalia Baselga Torres
    • 14:32
      O062 Utility of Prolonged Monitoring During Initiation of Oral Propranolol for Infantile Hemangioma

      Leanna Hansen, Denise Adams, Eulalia Baselga Torres, Sarah Chamlin, Kristen Corey, Flora Frascari, Ilona Frieden, Peter Frommelt, Eloise Galligan, Maria Garzon, Kimberly Horii, Justyna Klajn, Christine Lauren, Anthony Mancini, Diana Mannschreck, Erin Mathes, Anelah McGinness, Brandon Newell, Henry Nguyen, Amy Nopper, Tola Oyesanya, Kate Puttgen, Megan Reynolds, Dawn Siegel, Nicole Stefanko, Megha Tollefson and Beth Drolet
    • 14:39
      O063 AQP1 plays a key role in propranolol response in vivo

      Francois Moisan, Priscilla Kaulanjan, Sorilla Prey, Maya Loot, Christine Léauté Labreze, Alain Taieb and Hamid Rezvani
    • 14:46
      O064 Propranolol treatment does not affect growth and development of children with infantile hemangioma

      Andre Moyakine
    • 14:53
      O065 Hemangioma Sequelae In Infantile Hemangiomas Treated With Propranolol

      Eulalia Baselga, may el hachem, Andrea Diociaiuti, Claudia Carnevale, Camila Downey, Esther Roe, Iria Neri, Miriam Leuzzi, Jose Bernabeu-Wittel, M Teresa Montserrat-Garcia, Alejandro Ortiz-Prieto, antonio torrelo, Nicole Knopfel, Nadia Vercellino, Francesca Manunza, M Antonia Gonzalez-Enseñat, M Asuncion Vicente-Villa and ignasi Gich
    • 15:00
      O066 The positive predictive value of hemangioma location for risk of PHACE syndrome: a retrospective analysis

      Colleen Cotton, Jusleen Ahluwalia, Ilona Frieden, Leslie Castelo-Soccio, Elena Pope, Dawn Siegel, Esteban Fernandez-Faith, Kim Morel, Christine Lauren, Maria Garzon, Anthony Mancini, Sarah Chamlin, Anita Haggstrom, Megha Tollefson, Marilyn Liang, Sharon G
    • 15:07
      O067 Sternal/Midline Anomalies in PHACE Syndrome

      Nicole Stefanko, Beth Drolet, Olayemi Sokumbi, Ilona Frieden, Renee Howard, Juan Carlos Lopez Gutierrez, Maria Garzon, Eloise Galligan, Denise Metry, Francine Blei, Janet Fairley, Deborah Goddard and Dawn Siegel
  • 15:15
    Coffee Break
  • Difficult Cases 3

    Moderators: Beth Drolet & Lisa Weibel
    • 15:45
      O068 Necrotizing Infection of an Infantile Hemangioma: An Uncommon Complication of a Common Disorder

      Bridget Shields, Lauren Brin Hermans, Beverly Aagaard-Kienitz, David Wargowski, Darya Buehler, Jason Pinchot, Carrie Kovarik, Lisa Arkin and Catharine Garland
    • 15:54
      O069 Primary Hepatic Angiosarcoma in a 3 year-old Child Complicated by Consumptive Hypothyroidism: A Case Report

      Lara Mrak, Michael Woods, Carol Diamond, Jason Pinchot, Beverly Aagaard Kienitz, Lisa Arkin, Paula North, Darya Buehler and Kara Gill
    • 16:03
      O070 Controversy RICH or KHE? What constitutes a true Kasabach Merritt syndrome? Necrotizing fasciitis in vascular anomalies: Seeking other centers experience, prevention?

      Catherine McCuaig, Michele David, Patricia Bortoluzzi, Louise Laberge, Elizabeth Rousseau, Afshin Hatami, Sandra Ondrejchak and Josée Dubois
    • 16:12
      O071 Fatal hemorrhage from a rapidly involuting congenital hemangioma in an infant

      Aicha Salhi, Warda Drali, Nora Cheddani, Toufik Tounsi, Assya Djeridane, Abdelhamid Aitbenamar, Zoheir Belkaid and Ismail Benkaidali
  • 19:00
    Social Event - Congres Dinner (ticketed)

  • Friday 01 June 2018
  • Scientific Session 6: Lymphedema and Lymphatic Malformations

    Moderators: Michael Dellinger & Tony Pennington
    • 08:00
      O072 Lymphoscintigraphic Evaluation of Systemic Tracer Uptake in Patients with Primary Lymphedema and Establishment of an Evidenced-Based Protocol

      Arin Greene, Aladdin Hassanein, David Zurakowski, Frederick Grant, Stephan Voss and Reid Macllellan
    • 08:09
      O073 Proliferative Cells Resembling Mesenchyme Stem Cell-like Pericytes Derived from Kaposiform Hemangendothelioma and Kaposiform Lymphangiomatosis Lesions

      Kathryn Glaser, Peter Dickie, Denise Adams and Belinda Dickie
    • 08:18
      O074 Kaposiform Lymphangiomatosis Caused by a Somatic NRAS Mutation

      Daniel M Balkin, Carol Nelson-Williams, Kristin Shimano, Tippi MacKenzie, Jessica L Davis, William Y Hoffman, Richard P Lifton and Ilona J Frieden
    • 08:25
      O075 Generalized Lymphatic Anomaly Is Caused By Somatic Activating PIK3CA Mutations

      Lara Rodriguez Laguna, Noelia Agra, Gema Gordo Trujillo, Noor Khurana, Devon Hominick, Pablo Lapunzina, Juan Carlos Lopez-Gutierrez, Michael Dellinger and Victor Martinez-Glez
    • 08:32
      O076 Lobular Capillary-Lymphatic Malformation of Subcutis: a Newly Recognized Entity with Distinctive Histological and Clincial Features

      Paula North and Valerie Salato
    • 08:41
      O77 Prenatally diagnosed lymphatic malformations: clinical characteristics and outcomes

      Nancy Wang, Isabelle Chumfong, Lan Vu, Ilona Frieden, Kristina Rosbe and Josephine Czechowicz
    • 08:48
      O078 ADAMTS3 Mutations cause Hennekam Lymphangiectasia-Lymphedema Syndrome 3

      Miikka Vikkula, Pascal Brouillard, Laura Dupont, Raphaël Helaers, Richard Coulie, George E. Tiller, Joseph Peeden and Alain Colige
    • 08:55
      O079 Somatic NRAS mutation in patient with Generalized Lymphatic Anomaly

      Eugenia Manevitz-Mendelson, Gil S. Leichner, Ortal Barel, Inbal Davidi-Avrahami, Limor Strasser Ziv, Eran Eyal, Itai Pessach, Uri Rimon, Aviv Barzilai, Ninette Amariglio, Gideon Rechavi, Karina Yaniv and shoshana Greenberger
    • 09:02
      O080 Kaposiform hemangioendothelioma: clinical features, complications and risk factors for Kasabach-Merritt phenomenon

      Yi Ji, Siyuan Chen and Bo Xiang
    • 09:09
      O081 Dynamic contrast enhanced MR lymphangiography in patients with lymphatic anomalies.

      Maxim Itkin and Gregory Nadolski
    • 09:18
      O082 A feasibility study to demonstrate the use of Near Infrared Fluorescent Lymphatic Imaging (NIRFLI) to diagnose and direct treatment in pediatric patients with lymphatic anomalies

      Rodrick Zvavanjanja, John Rasmussen, Adelaide Hebert, Eva Sevick and Matthew Greives
    • 09:25
      O083 Differences in clinical findings and plasma cytokine profiles between generalized lymphatic anomaly and kaposiform lymphangiomatosis

      Michio Ozeki, Akifumi Nozawa, Norio Kawamoto, Akihiro Fujino, Satoshi Hirakawa and Toshiyuki Fukao
    • 09:34
      O084 Lymphatic malformations treated by venous anastomosis technique based on flow assessment.

      Motoi Kato, Shoji Watanabe and Azusa Watanabe
    • 09:43
      O085 Phase II Study of Sirolimus and Complicated Vascular Anomalies: Long term outcomes in Kaposiform Hemangioendothelioma

      Denise Adams, Cameron Trenor, Kiersten Ricci, Manish Patel, Gulraiz Chaudry, Megan Metcaff, Paula Mobberley-Schuman, Justyna Klajn, Anita Gupta, Carol Chute, Arnold Merrow, roshni dasgupta, Belinda Dickie and Adrienne Hammill
    • 09:52
      O086 A Multidisciplinary Team Approach to Effectively Treat Abdominal Lymphatic Malformations

      Wesley Barry, Donna Nowicki, Minna Wieck, Kathy Schall, Minnelly Luu, Lori Howell, Chadi Zeinati and Dean Anselmo
  • 10:00
    Coffee Break

  • Difficult Cases 4

    Moderators: Jochen Roessler & Adrienne Hammill
    • 10:30
      O087 Generalised Lymphatic Anomaly Treated with Sirolimus and Bevacizumab

      Tamás Budi (Semmelweis University, 2nd Dept. of Paediatrics); Zsuzsa Nagy (Semmelweis University, Budapest); Edit Varga (Semmelweis University, Budapest); György Balázs (Semmelweis University, Budapest); Zoltán Jenovári (Semmelweis University, Budapest)
    • 10:39
      O088 Difficult case of a lymphedema patient with deteriorating venous outflow of lower limbs

      Tamás Budi, Zsuzsa Nagy, Edit Varga, György Balázs and Zoltán Jenovári
    • 10:48
      O089 Case of Multifocal Lymphangioendotheliomatosis with Thrombocytopenia (MLT)…without thrombocytopenia and with minimal cutaneous involvement

      Priya Mahajan, Judith Margolin and Ionela Iacobas
    • 10:57
      O090 Diagnostic and Management Dilemma in a Neonate

      Ionela Iacobas, Priya Mahajan, Sudhen Desai, Judith Margolin, Tara Rosenberg and Sheena Pimpalwar
  • Scientific Session 7: Vascular Malformations Surgery, Interventional Radiology, and Imaging

    Moderators: David Darrow & Patricia Burrows
    • 11:10
      O091 Facial reanimation in patients with flaccid facial paralysis after excision of facial vascular anomalies

      Teresa O, Milton Waner and Ho Yun Chung
    • 11:19
      O092 Three Thousand Sclerotherapy Treatments of Vascular Anomalies with Intralesional Bleomycin Injection

      Tobian Muir, Sri Murugan, Gareth Kessell, Raj Jayaraj, Sheamus Fitzgerald and Rajeev Padmanhaban
    • 11:28
      O093 Operative treatment of lower extremity venous malformations

      Pia Vuola, Jussi Repo, Päivi Salminen, Johanna Aronniemi, Kimmo Lappalainen and Erkki Tukiainen
    • 11:37
      O094 Effectiveness and safety of balloon-assisted sclero-embolotherapy for subcutaneous arteriovenous malformations

      Shigeki Imai and Tomomi Sato
    • 11:44
      O095 Ethylene vinyl alcohol copolymer in the treatment of high flow arteriovenous vascular malformations: Long- term results and histology

      Antoinette Gomes, Phillip Monteleone, Alison Vasan , James Sayre and Susan Bukata
    • 11:51
      O096 Ethanol embolization combined or not with surgery and close clinical follow-up can effectively control extracranial arterio-venous malformations (AVMs)

      Jean Nicolas Racicot, Josee Dubois, Patrick Gilbert, Patricia Bortoluzzi, Julie Powell, Alain Danino, Marie-France Giroux and Gilles Soulez
    • 11:55
      O097 Efficacy of flow related color-coded DSA in direct puncture treatment of arteriovenous malformations.

      Kunie Ohuchi, Shiro Onozawa, Yoshiaki Katada, Goro Takada and Rintaro Akimoto
  • 12:05
    Lunch & Poster Viewing

  • 12:30
    Lunch Symposium (company sponsored - non-CME)

    Moderators: Gilles Soulez & Chantal van der Horst
  • Scientific Session 8: Vascular Malformations Potpourri

    Moderators: Gilles Soulez & Chantal van der Hors
    • 13:30
      O098 Hormone Receptors Expression in Microvascular Proliferation of Arteriovenous Malformation

      Amalia Mulia Utami, Onno J. de Boer, Dara R. Pabittei, Claire Mackaaij and Allard C. van der Wal
    • 13:39
      O099 Electrosclerotherapy as a novel treatment option for hypertrophic capillary malformations: proof of concept

      Sophie E.R. Horbach, Albert Wolkerstorfer, Folkert Jolink, Paul R. Bloemen and Chantal M.A.M. van der Horst
    • 13:48
      O100 Bleomycin Electrosclerotherapy (EST); an Exciting Emerging Treatment in the Management of Vascular Malformations

      Tobian Muir, Liam McMorrow, Sri Murugan, Gareth Kessell and Raj Jayaraj
    • 13:57
      O101 Pregnancy in Women with Klippel-Trenaunay Syndrome: Report of a Complicated Case and Proposal for Standardized Care

      Max M. Lokhorst, Sophie E.R. Horbach, J.W. Ganzevoort, S. Middeldorp, CE Oduber and C.M.A.M. van der Horst
    • 14:06
      O102 Chitosan-doxycycline hydrogel: An MMP inhibitor/sclerosing embolizing agent as a new approach to treat AVMs and LM.

      Gilles Soulez, Fatemeh Zehtabi, Pompilia Ispas-Szabo, Djahida Djerir, Lojan Sivakumaran, Mircea Alexandru Mateescu and Sophie Lerouge
    • 14:15
      O103 Pre-operative percutaneous n-BCA glue embolization of truncal and extremity venous malformations: technique, safety, and clinical outcomes

      Giridhar Shivaram, Eric Monroe, Rush Chewning, Antoinette Lindberg, Kevin Koo, Randall Bly and Jonathan Perkins
    • 14:22

      Claude Laurian, Veronique Marteau, Claudine Massoni, Pierre Cerceau, Akli Zetchi, Nikos Paraskevas, Emmanuel Houdart and Annouk Bisdorff Bresson
    • 14:29
      O105 In the Age of B-Blockers Is There A Role For Surgery To Manage Infantile Hemangioma in Sensitive Facial Anatomical Regions?

      Jugpal Arneja
    • 14:38
      O106 Comparison of two generation photosensitizers of PsD-007 and HMME photodynamic therapy for treatment of port-wine stain: a retrospective study.

      Gang Ma, Yue Han, Wenxin Yu, Jiafang Zhu, Yajing Qiu, Hui Chen, Yunbo Jin and Lin Xiaoxi
    • 14:47
      O107 Diagnosis and Treatment of Hepatic Venous Malformations

      Wayne Yakes
    • 14:55
      O108 Imaging of Epithelioid Hemangioendothelioma

      Yan Epelboym, Frederic Thomas-Chausse, Ahmad Alomari, Cameron Trenor, Denise Adams and Gulraiz Chaudry
  • 15:00
    Coffee Break
  • Difficult Cases 5

    Moderators: Milton Waner & Gresham Richter
    • 15:30
      O109 Management of a massive right lower extremity and buttock venous malformation requiring abdominoperineal resection

      Wesley Barry, Donna Nowicki, Chadi Zeinati, Minnelly Luu, Lori Howell and Dean Anselmo
    • 15:39
      O110 Unclear Diagnosis and Management of A Congenital Nasal Vascular Lesion

      Nancy Bauman, Gina Krakovsky, Phillip Guzzetta, Bhupender Yadav, Albert Oh, Yasmine Kirkorian, Monica Pearl, Christopher Rossi, Bernard Cohen and Amir Dorafshar
    • 15:48
      O111 Transvenous and image-guided embolization techniques combined with surgical reconstruction for difficult AVMS of the head and neck.

      Alejandro Berenstein, Milton Waner, Priya Kesarwani And Teresa O
    • 15:57
      O112 Complex bilateral cervicofacial lymphatic malformation mandibular deformity in pediatric patient

      Tara Rosenberg, Ionela Iacobas, Priya Mahajan, Judith Margolin, Raphael J. Yoo and Sheena Pimpalwar
  • 16:05
    Award Ceremony & Closing

  • 17:00
    Farewell Reception